| Number of Patients, Male | 0 |
| Number of Patients, Female | 6 |
| Stage | Metastatic, 6 |
| Age | Median (range): 69.5 (62–81) years |
| Number of Prior Systemic Therapies | Median: null |
| Performance Status: ECOG | 0 — 2 1 — 4 2 — 0 3 — 0 Unknown — 0 |
| Cancer Types or Histologic Subtypes | Breast carcinoma, 6 |
| Number of Patients, Male | 0 |
| Number of Patients, Female | 6 |
| Stage | Metastatic, 6 |
| Age | Median (range): 69.5 (62–81) years |
| Number of Prior Systemic Therapies | Median: null |
| Performance Status: ECOG | 0 — 2 1 — 4 2 — 0 3 — 0 Unknown — 0 |
| Cancer Types or Histologic Subtypes | Breast carcinoma, 6 |
| Number of Patients, Male | 0 |
| Number of Patients, Female | 6 |
| Stage | Metastatic, 6 |
| Age | Median (range): 69.5 (62–81) years |
| Number of Prior Systemic Therapies | Median: null |
| Performance Status: ECOG | 0 — 2 1 — 4 2 — 0 3 — 0 Unknown — 0 |
| Cancer Types or Histologic Subtypes | Breast carcinoma, 6 |
| Number of Patients, Male | 0 |
| Number of Patients, Female | 6 |
| Stage | Metastatic, 6 |
| Age | Median (range): 69.5 (62–81) years |
| Number of Prior Systemic Therapies | Median: null |
| Performance Status: ECOG | 0 — 2 1 — 4 2 — 0 3 — 0 Unknown — 0 |
| Cancer Types or Histologic Subtypes | Breast carcinoma, 6 |
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.
